In focus · trending topic

extended release tablets

1 stories · following the connections

FABRE-KRAMER PARTNERS WITH MISSION PHARMACAL FOR FUTURE COMMERCIAL MANUFACTURE OF NOVEL MECHANISM ANTIDEPRESSANT TRAVIVO™ (GEPIRONE HCL) TABLETS

By Nasdaq OMXJan 3, 2018, 4:26 PM UTC